Cortina Asset Management Has Lifted Position in Ligand Pharmaceuticals (LGND); Banco Macro Sa Spon Adr B (BMA) Share Value Rose While Sloane Robinson Llp Has Lifted Its Position

November 15, 2017 - By Adrian Mccoy

Cortina Asset Management Llc increased its stake in Ligand Pharmaceuticals (LGND) by 31.27% based on its latest 2017Q2 regulatory filing with the SEC. Cortina Asset Management Llc bought 15,967 shares as the company’s stock rose 7.66% with the market. The institutional investor held 67,026 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $8.14 million, up from 51,059 at the end of the previous reported quarter. Cortina Asset Management Llc who had been investing in Ligand Pharmaceuticals for a number of months, seems to be bullish on the $3.06B market cap company. The stock increased 1.59% or $2.27 during the last trading session, reaching $145.07. About 14 shares traded. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has declined 2.87% since November 15, 2016 and is downtrending. It has underperformed by 19.57% the S&P500.

Hugh Sloane increased its stake in Banco Macro Sa Spon Adr B (BMA) by 158.2% based on its latest 2017Q2 regulatory filing with the SEC. Sloane Robinson Llp bought 19,300 shares as the company’s stock rose 7.03% with the market. The hedge fund run by Hugh Sloane held 31,500 shares of the commercial banks company at the end of 2017Q2, valued at $2.90 million, up from 12,200 at the end of the previous reported quarter. Sloane Robinson Llp who had been investing in Banco Macro Sa Spon Adr B for a number of months, seems to be bullish on the $6.59 billion market cap company. The stock decreased 14.37% or $16.38 on November 14, reaching $97.61. About shares traded. Banco Macro SA (ADR) (NYSE:BMA) has risen 43.80% since November 15, 2016 and is uptrending. It has outperformed by 27.10% the S&P500.




More notable recent Ligand Pharmaceuticals Inc. (NASDAQ:LGND) news were published by: Nasdaq.com which released: “Ligand (LGND) Q3 Earnings & Revenues Top, 2017 View Raised” on November 10, 2017, also Zacks.com with their article: “What’s in Store for Ligand (LGND) This Earnings Season?” published on November 06, 2017, Nasdaq.com published: “Ligand Pharmaceuticals Inc Announces 59% Advance In Q3 Earnings” on November 09, 2017. More interesting news about Ligand Pharmaceuticals Inc. (NASDAQ:LGND) were released by: Reuters.com and their article: “BRIEF-Ligand Pharmaceuticals says signed license and supply agreement via …” published on November 13, 2017 as well as Nasdaq.com‘s news article titled: “AstraZeneca Gets Positive CHMP Opinion for Asthma Candidate” with publication date: November 13, 2017.

Among 5 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Ligand Pharmaceuticals had 21 analyst reports since September 3, 2015 according to SRatingsIntel. TH Capital maintained the stock with “Buy” rating in Thursday, November 19 report. The company was maintained on Wednesday, September 30 by Roth Capital. The rating was maintained by TH Capital on Wednesday, September 30 with “Buy”. Roth Capital maintained the stock with “Buy” rating in Monday, September 21 report. TH Capital maintained the shares of LGND in report on Friday, December 18 with “Buy” rating. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Buy” rating by Roth Capital on Thursday, September 3. As per Tuesday, September 5, the company rating was reinitiated by H.C. Wainwright. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has “Buy” rating given on Monday, November 13 by Roth Capital. The stock has “Buy” rating by Roth Capital on Friday, December 18. The firm earned “Hold” rating on Tuesday, August 8 by Deutsche Bank.

Since June 9, 2017, it had 0 insider purchases, and 1 insider sale for $1.38 million activity.

Cortina Asset Management Llc, which manages about $2.83B and $2.36B US Long portfolio, decreased its stake in Beacon Roofing Supply Inc (NASDAQ:BECN) by 6,483 shares to 508,937 shares, valued at $24.94M in 2017Q2, according to the filing. It also reduced its holding in Dolby Laboratories Inc (NYSE:DLB) by 34,357 shares in the quarter, leaving it with 84,641 shares, and cut its stake in Planet Payment Inc (NASDAQ:PLPM).

Investors sentiment increased to 1.24 in Q2 2017. Its up 0.06, from 1.18 in 2017Q1. It is positive, as 22 investors sold LGND shares while 79 reduced holdings. 36 funds opened positions while 89 raised stakes. 22.57 million shares or 0.91% more from 22.37 million shares in 2017Q1 were reported. American International invested in 0.01% or 15,161 shares. Ny State Common Retirement Fund, New York-based fund reported 57,020 shares. Herndon Cap Mngmt Limited Com accumulated 168 shares. Alliancebernstein Limited Partnership has invested 0% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). 1,127 are held by Da Davidson & Communication. Fifth Third Commercial Bank holds 5,097 shares. Solutions Ltd Llc accumulated 0% or 50 shares. Jefferies Grp Limited Liability, New York-based fund reported 1,700 shares. 16,760 are owned by Nordea Management Ab. Next Century Growth Invsts Limited Liability Company stated it has 1.4% of its portfolio in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). 27,116 were reported by Tocqueville Asset Mgmt Lp. Piedmont Investment Lc has 0.01% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) for 4,116 shares. Ameritas Inv Prns invested in 0.01% or 1,799 shares. Virginia Retirement Et Al stated it has 4,200 shares. Pitcairn accumulated 1,909 shares.

Among 5 analysts covering Banco Macro SA (NYSE:BMA), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Banco Macro SA had 7 analyst reports since February 9, 2016 according to SRatingsIntel. The stock has “Buy” rating by Credit Suisse on Tuesday, June 13. The firm has “Neutral” rating given on Wednesday, June 1 by UBS. Goldman Sachs downgraded it to “Hold” rating and $113.7 target in Monday, September 11 report. The rating was upgraded by Citigroup on Monday, May 23 to “Neutral”. The rating was initiated by Credit Suisse with “Neutral” on Tuesday, March 29. Goldman Sachs upgraded Banco Macro SA (ADR) (NYSE:BMA) on Monday, September 26 to “Buy” rating.

Another recent and important Banco Macro SA (ADR) (NYSE:BMA) news was published by Nasdaq.com which published an article titled: “What Lies Ahead for Argentina ETFs?” on November 08, 2017.

Sloane Robinson Llp, which manages about $156.39M US Long portfolio, decreased its stake in Pampa Energia S A Spons Adr Lvl I (NYSE:PAM) by 8,700 shares to 35,500 shares, valued at $2.09M in 2017Q2, according to the filing. It also reduced its holding in 58 Com Inc Spon Adr Rep A (NYSE:WUBA) by 359,200 shares in the quarter, leaving it with 11,600 shares, and cut its stake in Adecoagro S A Com (NYSE:AGRO).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.